Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel biologic approaches to hematologic malignancies

J P Dutcher1, P H Wiernik

  • 1Albert Einstein Cancer Center, Montefiore Medical Cancer, Bronx, New York 10467, USA.

Cancer Treatment and Research
|January 19, 1999
PubMed
Summary

Biologic agents are revolutionizing hematologic malignancy treatment. Further research into combining these agents with cytotoxic therapy may yield even greater success in treating blood cancers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overall survival by clinical risk category for high dose interleukin-2 (HD IL-2) treated patients with metastatic renal cell cancer (mRCC): data from the PROCLAIM<sup>SM</sup> registry.

Journal for immunotherapy of cancer·2019
Same author

A phase I study of cabozantinib (XL184) in patients with renal cell cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Characterization of bone metastases in patients with renal cell cancer.

BJU international·2004
Same author

Accelerated and blastic phase of chronic myeloid leukemia.

Current treatment options in oncology·2002
Same author

Phase I study of recombinant human CD40 ligand in cancer patients.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
Same author

Angiogenesis and melanoma.

Current oncology reports·2001

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Biologic agents have significantly impacted hematologic malignancy treatment.
  • Understanding their role in cell regulation is key to future advancements.

Purpose of the Study:

  • To introduce the potential of biologic agents in cancer therapy.
  • To highlight the need for further investigation into combination therapies.

Main Methods:

  • Review of current literature on biologic agents in hematologic malignancies.
  • Discussion of potential therapeutic strategies.

Main Results:

  • Biologic agents show considerable promise in treating blood cancers.
  • Existing examples illustrate their significant impact.

Conclusions:

  • Biologic agents will continue to be crucial in hematologic malignancy treatment.
  • Combining biologic agents with cytotoxic therapy warrants further investigation for enhanced efficacy.

Related Experiment Videos